The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells

Immunology

Volumn 88, Issue 1, 1996, Pages 35-39

  Henchoz Lecoanet, S ^a   Jeannin, P ^a   Aubry, J P ^a   Graber, P ^a   Bradshaw, C G ^a   Pochon, S ^a   Bonnefoy, J Y ^a  

^a GLAXO INST FOR MOLECULAR BIOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; FC RECEPTOR; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 4; SYNTHETIC PEPTIDE;

ARTICLE; B LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; PRIORITY JOURNAL; TONSIL CELL;

EID: 0029889305     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1996.d01-651.x     Document Type: Article

References (35)

1. NADLER L.M., STATSHENKO P., HARDY R., VON AGTHOVEN C., TERHORST C. & SCHLOSSMAN S.F. (1981) Characterization of a human B cell specific antigen (B2) distinct from B1. J Immunol 126, 1941.
2. FISCHER E., DELIBRIAS C. & KAZATCHKINE M. (1991) Expression of CR2 (the C3d,g/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol 146, 865.
3. REYNES M., AUBERT J-P., COHEN J.H. et al. (1985) Human follicular dendritic cells express CR1, CR2 and CR3 complement receptor antigens. J Immunol 135, 2687.
4. YOUNG L.S., CLARK D., SIXBEY J.W. & RICKINSON B. (1986) Epstein-Barr virus receptors on human pharyngeal epithelia. Lancet 1, 240.
5. WEIS J.J., TEDDER T.F. & FEARON D.T. (1984) Identification of a 145000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci USA 81, 881.
6. NEMEROW G.R., MOLD C., SCHWEND V.K., TOLLEFSON V. & COOPER N.R. (1987) Identification of gp 350 as the viral glycoprotein mediating attachment of Epstein Barr Virus (EBV) to the EBV/ C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61, 1416.
7. TANNER J., WEIS J., FEARON D., WHANG Y. & COOPER N.R. (1987) Epstein-Barr virus gp 350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis. Cell 50, 203.
8. DELCAYRE A., SALAS F., MATHUR S., KOVATS K., LOTZ M. & LERNHARDT W. (1991) Epstein-Barr virus/complement C3d receptor is an interferon a receptor. EMBO J 10, 919.
9. YUKAWA K., KIKUTANI H., OWAKI H. et al. (1987) A B-cell specific differentiation antigen, CD23, is a receptor for IgE (FceR) on lymphocytes. J Immunol 138, 2576.
10. BONNEHOY J-Y., AUBRY J-P., PERONNE C., WIJDENUS J. & BANCHEREAU J. (1987) Production and characterization of a mAb specific for the human lymphocyte low affinity receptor for IgE: CD23 is a low affinity receptor for IgE. J Immunol 138, 2970.
11. AUBRY J-P., POCHON S., GRABER P., JANSEN K. & BONNEFOY J-Y. (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358, 505.
12. AUBRY J-P, SHIELDS J.G., JANSEN K.U. & BONNEFOY J-Y. (1993) A multiparameter flow cytometric method to study surface molecules involved in interactions between subpopulations of cells. J Immunol Methods 159, 161.
13. BJORCK P., ELENSTRÖM-MAGNUSSON C., ROSÉN A., SEVERINSON E. & PAULIE S. (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur J Immunol 23, 1771.
14. FLORES-ROMO L., SHIELDS J., HUMBERT Y. et al. (1993) Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science 261, 1038.
15. CAIRNS J. & GORDON J. (1990) Intact, 45kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts. Eur J Immunol 20, 539.
16. JANSEN K.U., SHIELDS J., GORDON J., CAIRNS J., GRABER P. & BONNEFOY J-Y. (1991) Expression of human recombinant CD23 in insect cells. J Recept Res 11, 507.
17. MOSSALAYI M.D., LECRON J.C., DALLOUL A.H. et al. (1990) Soluble CD23 (FcεRII) and interleukin-1 synergistically induce early human thymocyte maturation. J Exp Med 171, 959.
18. MOSSALAYI M.D., AROCK M., BERTHO J.M. et al. (1990) Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 75, 1924.
19. LIU Y.J., CAIRNS J.A., HOLDER M.J. et al. (1991) Recombinant 25kDa CD23 and interleukin-1 alpha promote the survival of germinal center cells. Eur J Immunol 21, 1107.
20. BONNEFOY J.Y., HENCHOZ S., HARDIE D., HOLDER M.J., & GORDON J. (1993) A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apotosis. Eur J Immunol 23, 969.
21. BACON K., GAUCHAT J-F., AUBRY J-P. et al. (1993) CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti-CD21 antibodies. Eur J Immunol 23, 2721.
22. MOORE M.D., COOPER N.R., TACK B.F. & NEMEROW G. (1987) Molecular cloning of the cDNA encoding the Epstein-Barr virus C3d receptor (complement receptor type 2) of human B lymphocyte. Proc Natl Acad Sci USA 84, 9194.
23. WEIS J.J., TOOTHAKER L.E., SMITH J.A., WEIS J.H. & FEARON D.T. (1988) Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med 167, 1047.
24. CAREL J-C., MYONES B.L., FRAZIER B. & HOLERS V.M. (1990) Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. J Biol Chem 265, 12293.
25. AUBRY J-P., POCHON S., GAUCHAT J-F. et al. (1994) CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J Immunol 152, 5806.
26. SERVIS C. & LAMBRIS J.D. (1989) C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. J Immunol 142, 2207.
27. POCHON S., GRABER P., YEAGER M. et al. (1992) Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J Exp Med 176, 389.
28. CLAASSEN J.L., LERME A.D. & BUCKLEY R.H. (1990) A cell culture system that enhances mononuclear cells IgE synthesis induced by recombinant interleukin-4. J Immunol Methods 126, 213.
29. BONNEFOY J-Y., SHIELDS J. & MERMOD J-J. (1990) Inhibition of human interleukin-4-induced IgE synthesis by a subset of anti- CD23/Fc epsilon RII monoclonal antibodies. Eur J Immunol 20, 139.
30. MOORE M.D., CANNON M.J., SEWALL A., FINLYSON M., OKIMOTO M. & NEMEROW G.R. (1991) Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats. J Virol 61, 3559.
31. HENCHOZ S., GAUCHAT J-F., AUBRY J-P., GRABER P., POCHON S. & BONNEFOY J-Y. (1994) Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co- signal to modulate ε transcripts. Immunology 81, 285.
32. THYPHRONITIS G., TSOKOS G.C., JUNE C.H., LEVINE A.D. & FINKELMAN F.D. (1989) IgE secretion by Epstein-Barr virus infected purified human B lymphocytes is stimulated by interleukin-4 and suppressed by interferon-γ. Proc Natl Acad Sci USA 86, 5580.
33. LUNDGREN M., PERSSON U., LARSSON P. et al. (1989) Interleukin-4 induces synthesis of IgE and IgG4 in human B cells. Eur J Immunol 19, 1311.
34. PENE J., ROUSSET F., BRIERE F. et al. (1988) IgE production by normal human lymphocytes is induced by IL-4 and suppressed by α-interferon, γ-interferon and prostaglandin E2. Proc Nail Acad Sci USA 85, 8166.
35. UZE G., LUTFALLA G. & GRESSER I. (1990) Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225.